Advanced Solid Tumors Stocks List for 2021 | NYSE,

Advanced Solid Tumors Related ETFs
Recent Technical Analysis Signals
Recent Advanced Solid Tumors Stock News

Symbol	Grade	Name	% Change
CBLI	C	Cleveland BioLabs, Inc.	-1.82
CRDF	F	Cardiff Oncology, Inc.	-8.92
CASI	D	CASI Pharmaceuticals, Inc.	-3.24
CLRB	D	Cellectar Biosciences, Inc.	-7.46
SLRX	C	Salarius Pharmaceuticals, Inc.	-13.90
PPBT	F	Purple Biotech Ltd.	0.67
TPTX	D	Turning Point Therapeutics, Inc.	-4.49
ADCT	F	ADC Therapeutics SA	-6.13
RLAY	F	Relay Therapeutics, Inc.	-2.72
STTK	F	Shattuck Labs, Inc.	-1.20

View As Page of Charts

Related Industries: Biotechnology Diagnostics & Research Other

Related ETFs - A few ETFs which own one or more of the above listed Advanced Solid Tumors stocks.

Symbol	Grade	Name	Weight
LRNZ	D	TrueMark Technology, AI & Deep Learning ETF	3.85
XBI	D	SPDR Series Trust SPDR S&P Biotech ETF	2.02
MID	D	American Century Mid Cap Growth Impact ETF	1.63
GURU	C	Global X Top Guru Holdings Index ETF	1.47
CHNA	C	Loncar China BioPharma ETF	1.31

View all Advanced Solid Tumors related ETFs...

Compare ETFs

Compare GURU to CHNA

Compare LRNZ to GURU

Compare LRNZ to XBI

Recent Signals

Date	Stock	Signal	Type
2021-03-03	CLRB	Non-ADX 1,2,3,4 Bearish	Bearish Swing Setup
2021-03-03	CLRB	180 Bearish Setup	Bearish Swing Setup
2021-03-03	CRDF	Fell Below 200 DMA	Bearish
2021-03-03	PPBT	MACD Bearish Centerline Cross	Bearish

Recent News for Advanced Solid Tumors Stocks

Date	Stock	Title
Mar 3	SLRX	Salarius Pharmaceuticals readies stock offering
Mar 3	SLRX	Salarius Announces Proposed Public Offering of Common Stock
Mar 3	ADCT	Why ADC Therapeutics (ADCT) Might Surprise This Earnings Season
Mar 3	CRDF	Cardiff Oncology to Present at H.C. Wainwright Global Life Sciences Conference
Mar 3	PPBT	Purple Biotech Appoints Biopharmaceutical Industry Veteran Robert Gagnon to Board of Directors
Mar 2	PPBT	Purple Biotech reports FY results
Mar 2	CLRB	Cellectar Biosciences shares rise after FY results
Mar 2	CLRB	Cellectar Reports Financial Results for Year Ended December 31, 2020 and Provides a Corporate Update
Mar 2	PPBT	Purple Biotech Provides Corporate Update and Reports Second Half and Full Year 2020 Financial Results
Mar 2	TPTX	Turning Point Therapeutics, Inc. (TPTX) CEO Athena Countouriotis on Q4 2020 Results - Earnings Call Transcript
Mar 1	TPTX	Turning Point Therapeutics, Inc. 2020 Q4 - Results - Earnings Call Presentation
Mar 1	TPTX	Turning Point Therapeutics EPS misses by $0.09
Mar 1	TPTX	Turning Point Therapeutics Reports Fourth-Quarter and Full-Year Financial Results, Provides Operational Updates
Mar 1	TPTX	Turning Point Therapeutics, Inc. to Host Earnings Call
Mar 1	SLRX	SSYS, MARA, SOS and CAN among premarket gainers
Mar 1	TPTX	Earnings Scheduled For March 1, 2021
Feb 27	TPTX	The Week Ahead In Biotech (Feb. 28-March 6): KemPharm, Gilead FDA Decisions and More Earnings
Feb 27	CRDF	Could The Cardiff Oncology, Inc. (NASDAQ:CRDF) Ownership Structure Tell Us Something Useful?
Feb 27	RLAY	Relay Therapeutics: A Long-Term Position In Data-Driven Drug Developer Looks Attractive
Feb 26	CBLI	INVESTIGATION ALERT: Halper Sadeh LLP Investigates the Following Companies on Behalf of Shareholders - PAND, PRAH, AEGN, PTVCA, CRHM, CBLI, AKER

Browse All Tags